-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $53

Benzinga·02/13/2026 15:02:06
Listen to the news
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $37 to $53.